UK-based drug developers and contract manufacturers are set to find partners in the European Economic Area...
Up To Date
Latest News
Following a private placement worth CHF3m in February, Swiss allosteric modulator specialist Addex...
London-based orphan drug developer AMO Pharma’s drug AMO-02 has been granted FDA fast track status as...
French drug delivery specialist Biocorp S.A. (Issoire) has signed an...
Janssen speeds up US approval of psoriasis antibody guselkumab and targets further indications.
British Abzena plc has announced that True North Therapeutics (TNT) will be taken over by Bioverativ Inc....